{"id":"W4281763071","doi":"10.1200/jco.2022.40.16_suppl.tps2078","title":"GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Agile software development; Clinical trial; Randomization; Biomarker; Glioblastoma; Oncology; Protocol (science); Internal medicine; Medical physics; Pathology; Cancer research; Alternative medicine; Computer science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004115402,0.001203624,0.0008909675,0.0005211525,0.0003069282,0.0007799809,0.0007136957,0.0008645254,0.003752974],"category_scores_gemma":[0.002239908,0.0002984944,0.001410395,0.0004328916,0.0009642228,0.0009431307,0.001328493,0.002758879,0.0007778999],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009107778,"about_ca_system_score_gemma":0.002511257,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009844458,"about_ca_topic_score_gemma":0.002160065,"domain_scores_codex":[0.9988888,0.0007061425,0.00003974411,0.0001268807,0.0001144009,0.0001240145],"domain_scores_gemma":[0.9989021,0.000216767,0.0002203117,0.00009215769,0.00007789552,0.000490855],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4038015,0.0320741,0.01398155,0.00180627,0.002693534,0.0006079812,0.0005566904,0.01604702,0.02366997,0.00406657,0.05129702,0.4493979],"study_design_scores_gemma":[0.5911739,0.3216499,0.02445656,0.0003853412,0.001347997,0.001080327,0.0002503346,0.01331971,0.008855904,0.006333835,0.03102293,0.0001231107],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9456486,0.005220133,0.01346469,0.005107169,0.000664709,0.01095521,0.006559952,0.00145788,0.01092182],"genre_scores_gemma":[0.932112,0.002977791,0.02843039,0.006968477,0.0003368972,0.01287489,0.00924963,0.0003657991,0.006684113],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004115402,"threshold_uncertainty_score":0.02176458,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.6883699714316404,"score_gpt":0.658131808954005,"score_spread":0.03023816247763533,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}